Tuberculosis care does not end at treatment completion- a perspective from tuberculosis survivors

Lancet Infect Dis. 2021 Jul;21(7):896-897. doi: 10.1016/S1473-3099(20)30941-5. Epub 2021 Feb 25.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antitubercular Agents / therapeutic use
  • Humans
  • Survivors
  • Tuberculosis* / drug therapy

Substances

  • Antitubercular Agents